Rivaroxaban Sandoz,Xarelto® 20 mg
Sponsors
Novartis (Thailand) Ltd.
Conditions
Healthy volunteers
Healthy volunteers
Bioequivalence
Rivaroxaban
Pharmacokinetic study
Phase 1
A Bioequivalence Study of Two Formulations of 20-mg Rivaroxaban Tablets in Healthy Thai Volunteers under Fed Condition
Active, not recruitingTCTR20190503001
Start: 2019-08-06Target: 24Updated: 2026-08-03
A Bioequivalence Study of Two Formulations of 20-mg Rivaroxaban Tablets in Healthy Thai Volunteers under Fed Condition
Active, not recruitingTCTR20200513006
Start: 2020-08-25Target: 40Updated: 2026-08-03